Frank C. Brosius
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Animal Physiology Biology, Cell BiologyGoogle:
"Frank Brosius"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Choi YJ, Richard G, Zhang G, et al. (2024) Attenuated kidney oxidative metabolism in young adults with type 1 diabetes. The Journal of Clinical Investigation |
| Pyle L, Choi YJ, Narongkiatikhun P, et al. (2024) Proteomic Analysis Uncovers Multi-Protein Signatures Associated with Early Diabetic Kidney Disease in Youth with Type 2 Diabetes Mellitus. Clinical Journal of the American Society of Nephrology : Cjasn |
| Mathew AV, Kayampilly P, Byun J, et al. (2023) Tubular Dysfunction Impairs Renal Excretion of Pseudouridine in Diabetic Kidney Disease. American Journal of Physiology. Renal Physiology |
| Elzinga SE, Eid SA, McGregor BA, et al. (2023) Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type 1 and type 2 diabetes. Disease Models & Mechanisms. 16 |
| Baek J, Sas K, He C, et al. (2023) The Deacylase Sirtuin 5 Reduces Malonylation in Non-mitochondrial Metabolic Pathways in Diabetic Kidney Disease. The Journal of Biological Chemistry. 102960 |
| Schaub JA, AlAkwaa FM, McCown PJ, et al. (2023) SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth onset type 2 diabetes. The Journal of Clinical Investigation |
| Tuttle KR, Agarwal R, Alpers CE, et al. (2022) Molecular mechanisms and therapeutic targets for diabetic kidney disease. Kidney International |
| Eid SA, O'Brien PD, Hinder LM, et al. (2021) Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes. Journal of Translational Science. 7 |
| Wu L, Liu C, Chang DY, et al. (2021) Annexin A1 alleviates kidney injury by promoting the resolution of inflammation in diabetic nephropathy. Kidney International |
| Tuttle KR, Brosius FC, Cavender MA, et al. (2020) SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation |